View in EDS

Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.

Saved in:
Bibliographic Details
Title: Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.
Authors: Chaussin B; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France., Sanchez L; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France.; Service de Médecine Nucléaire, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Levesque S; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France.; Unité de Radiopharmacie, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Revy A; Unité de Radiopharmacie, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Tempier M; Unité de Radiopharmacie, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Montemagno C; Biomedical Department, Centre Scientifique de Monaco, Monaco, 98000, Monaco., Durivault J; Biomedical Department, Centre Scientifique de Monaco, Monaco, 98000, Monaco., Schmitt S; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France., Boutault E; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France.; Service de Pathologie, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Besse S; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France., Chautard E; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France.; Service de Pathologie, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Auriol M; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France., Voissiere A; INSERM U-1052, CNRS 5286, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, Lyon, France., Kossaï M; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France.; Service de Pathologie, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Miot-Noirault E; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France., Penault-Llorca F; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France.; Service de Pathologie, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Merlin C; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France.; Service de Médecine Nucléaire, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Cachin F; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France.; Service de Médecine Nucléaire, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France., Jouberton E; UMR1240 INSERM, IMoST, Université Clermont Auvergne, 58, rue Montalembert, 63005, Clermont-Ferrand, France. Elodie.JOUBERTON@clermont.unicancer.fr.; Service de Médecine Nucléaire, Centre Jean PERRIN, 58 rue Montalembert, 63011, Clermont-Ferrand, France. Elodie.JOUBERTON@clermont.unicancer.fr.
Source: Scientific reports [Sci Rep] 2026 Feb 16; Vol. 16 (1). Date of Electronic Publication: 2026 Feb 16.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2045-2322
DOI:10.1038/s41598-026-36724-7